Peng-Ju Chien

Title: Innovations in Anti-Cancer Treatment by Peng-Ju Chien

Introduction

Peng-Ju Chien is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment, particularly focusing on oral cancer. His innovative approach has led to the development of a unique method for preventing and treating this serious condition.

Latest Patents

Peng-Ju Chien holds a patent for the "Use of GMNL-346 for anti-oral cancer treatment and thereof." This patent describes a method that includes administering a composition comprising GMNL-346 or a supernatant of the heat-killed GMNL-346. The active ingredient in this composition has demonstrated an anti-oral cancer effect. The deposition number of GMNL-346 is BCRC 910953 or CCTCC M 2019983. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout his career, Peng-Ju Chien has been associated with Genmont Biotech Incorporation, where he has played a crucial role in research and development. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients suffering from oral cancer.

Collaborations

Peng-Ju Chien has collaborated with esteemed colleagues such as Wan-Hua Tsai and I-ling Hsu. These partnerships have enhanced the research efforts and have been instrumental in the successful development of innovative treatments.

Conclusion

Peng-Ju Chien's contributions to the field of anti-cancer treatment exemplify the impact of innovation in medicine. His work continues to inspire advancements that may lead to better health outcomes for patients facing oral cancer.